HbA1c reflects mean BG over the prior three to four months and is currently the only long-term glycemic control measure with robust outcome data. Multiple studies in diverse populations have shown that elevated HbA1c values are associated with chronic complications of diabetes. Intensive management resulting in lower HbA1c concentrations is associated with fewer and delayed development of microvascular and macrovascular chronic complications 1-5 , see Chapter 18 (ref). Additionally, lower HbA1c shortly after diagnosis is associated with a lower risk of subsequent complications 6,7 . This article is protected by copyright. All rights reserved.
ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes
L. Dimeglio,C. Acerini,E. Codner,M. Craig,S. Hofer,K. Pillay,D. Maahs
Published 2018 in Pediatric Diabetes
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Pediatric Diabetes
- Publication date
2018-10-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.